All issues
Volume 31 (2025)
- Issue 2 Pages 89-
- Issue 1 Pages 25-
Predecessor
Current issue
Displaying 1-2 of 2 articles from this issue
- |<
- <
- 1
- >
- >|
Case Report
-
Yuichiro Kawaguchi, Maiko Sekiguchi, Toshiroh Iwasaki2025 Volume 31 Issue 2 Pages 89-94
Published: 2025
Released on J-STAGE: June 20, 2025
JOURNAL FREE ACCESSA 13-year-old dachshund diagnosed with cutaneous epitheliotropic T-cell lymphoma showed erythema, scales, and pruritus on the left flank. Lokivetmab was administered at 10 mg, and pruritus disappeared. The treatment was continued every 4 weeks, but pruritus returned and the skin lesions gradually worsened. The dosage was increased to 30 mg/head, and not only pruritus but also the erythema and scales disappeared. Subsequently the dosage was increased by 10 mg, and finally to 50 mg. The patient died of acute pancreatitis 769 days after the start of treatment. Lokivetmab was effective against pruritus and skin lesions in this case, and may have extended the survival time.
View full abstractDownload PDF (2979K)
Letter
-
Yasutaka Oda, Keigo Suginohara, Emiko Kinoshita, Yamada Kakeru, Tomoya ...2025 Volume 31 Issue 2 Pages 95-97
Published: 2025
Released on J-STAGE: June 20, 2025
JOURNAL FREE ACCESSDownload PDF (1152K)
- |<
- <
- 1
- >
- >|